However, in alveolar macrophages from COPD patients, sulforaphane did increase Nrf2 target gene expression and enhanced bacterial phagocytosis in vitro [13], which indicates a capacity for stimulation. This evidence concerns the gene NFE2L2 and chronic obstructive pulmonary disease.